Trial in HPV Prevention for the U.S. Vietnamese Community
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorNorthwestern University
About this trial
The purpose of the HERO study is to leverage the Multiphase Optimization Strategy (MOST) framework to conduct a pilot trial testing four different intervention components (expert video, self-persuasion, narrative storytelling, and motivational interviewing) targeting HPV vaccination among U.S. Vietnamese.
PRIMARY AIM To assess the feasibility and acceptability of each of the four digital HERO intervention components in a pilot optimization trial using the MOST framework. Using a highly efficient design, the study team will randomize 96 Vietnamese parents of unvaccinated adolescents to receive 0 to 4 HERO components. The study team will establish the feasibility (reach, retention, adherence) and acceptability (usability, satisfaction, usefulness, cultural relevance) of each component (expert video, self-persuasion, narrative storytelling, and motivational interviewing).
SECONDARY AIM To investigate effects of each component on HPV vaccination outcomes and psychosocial mediators. The study team will examine the effects on HPV vaccination (initiation and intention) and psychosocial mediators.
Eligibility criteria
Qualifiers
Self-identify as U.S. Vietnamese.
Are the parent of a youth ages 9-18 who have not initiated the HPV vaccine series. Only one parent per household will be able to participate.
Have lived in the U.S. for 12 months or more.
Disqualifiers
Planning to move out of the U.S. within the next 6 months.
Not fluent in either spoken and written Vietnamese or spoken and written English.
Inability to provide informed consent.
Trial design
Treatments tested in this trial
- Expert Video
- Self-persuasion
- Narrative Storytelling
- Motivational Interviewing
- Constant Component
Treatment groups
96 Participants
are divided into 16 treatment groups16
Treatment groupsSee each treatment group below.
Sponsors and collaborators
Northwestern University
Lead sponsor
National Cancer Institute (NCI)
Collaborator
Source ClinicalTrials.gov